Application 212690

Type
NDA
Sponsor
JAZZ PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001XYWAVCALCIUM;MAGNESIUM;POTASSIUM;SODIUM OXYBATESSOLUTION;ORAL0.5MG/MLYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
68727-150XYWAV(calcium, magnesium, potassium, and sodium oxybates)Jazz Pharmaceuticals, Inc.NDACurrent
68727-150XYWAV(calcium, magnesium, potassium, and sodium oxybates)Jazz Pharmaceuticals, Inc.NDACurrent
68727-150XYWAV(calcium, magnesium, potassium, and sodium oxybates)Jazz Pharmaceuticals, Inc.NDACurrent
68727-150XYWAV(calcium, magnesium, potassium, and sodium oxybates)Jazz Pharmaceuticals, Inc.NDACurrent
68727-150XYWAV(calcium, magnesium, potassium, and sodium oxybates)Jazz Pharmaceuticals, Inc.NDACurrent
68727-150XYWAV(calcium, magnesium, potassium, and sodium oxybates)Jazz Pharmaceuticals, Inc.NDACurrent
68727-150XYWAV(calcium, magnesium, potassium, and sodium oxybates)Jazz Pharmaceuticals, Inc.NDACurrent
68727-150XYWAV(calcium, magnesium, potassium, and sodium oxybates)Jazz Pharmaceuticals, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
82976SUPPL 2025-07-29
82456SUPPL 2025-05-30
82298SUPPL 2025-05-23
80245SUPPL 2024-11-19
78549SUPPL 2024-05-23
77233SUPPL 2024-01-17
76530ORIG 2023-11-08
75672APPL 2023-10-04
74063SUPPL 2023-04-26
74062SUPPL 2023-04-26
73951SUPPL 2023-04-05
73290SUPPL2023-01-25
71951SUPPL2022-08-29
71858SUPPL2022-08-23
70137SUPPL2022-02-10
69544SUPPL2021-12-14
68372SUPPL2021-08-13
68371SUPPL2021-08-13
68368SUPPL2021-08-13
67900SUPPL2021-06-25
67442ORIG2021-05-07
66238SUPPL2021-02-17
66237SUPPL2021-02-17
66226SUPPL2021-02-16
66225SUPPL2021-02-16
64004ORIG2020-07-22
63994ORIG2020-07-22